supporting new cancer treatment
Intertek helped in the development of second-generation breast cancer treatment by helping to resolve the hold on a new drug during the approval process.
expertise that makes progress possible
While undergoing clinical trials for this important treatment, there were concerns about the immune response in the study samples, with an extraordinarily high rate of positives. As a result of these finding, the trials for this drug were placed on hold.
Intertek was able to independently test the data to help assess and solve the issue.
enabling pharma innovation
Over the last 20 years, our network of pharmaceutical scientists and regulatory experts has worked for many of the world’s largest and most innovative healthcare companies, and at every stage of development.
Industry-leading services
We provide contract pharmaceutical and biopharmaceutical laboratory services, supply chain audits and regulatory guidance, supporting drug development and production.
From early discovery through to late-stage clinical studies, our specialist teams provide essential knowledge, discretion, and capability where and when our clients need it.
science-based expertise
Our experts work with you at every stage of development, providing consistently high quality and flexible services that enable better treatments around the world and marketplace advantages for healthcare companies.
